All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Enclomiphene and MK-677 stacking claims: what the data says

derealization

TikTok creator

23.5K viewsWatch on TikTok→

Quick answer

The video contains no clinical claims about MK-677 or enclomiphene. The caption implies an update on both compounds, but the audio is song lyrics referencing mental illness and social fear. Viewers seeking compound information will find none here, and any health decisions about MK-677 or enclomiphene should be based on supervised lab work and licensed provider guidance, not social media captions.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @derealization0853 actually say?

Straightforwardly: nothing about peptides or performance compounds. The transcript is song lyrics. The creator sings, "I spent my whole life feeling awful cause I'm mentally ill" and references fear of people and "the way that they feel." There is no spoken claim about MK-677, enclomiphene, dosing, cycling, or any physiological effect. The caption mentions "enclo an mk update" but the video delivers zero informational content about either compound.

This matters because the video is being categorized as peptide content and is surfacing in feeds where people make health decisions. Context counts. A caption that reads like a compound update, paired with hashtags like gear and physique, creates an implied frame even when the audio contradicts it entirely.

Does the science back this up?

There is no science to evaluate here, because no claim was made. But since the caption invokes MK-677 and enclomiphene, it is worth addressing what the research actually says about both, so viewers who land here expecting an "update" get something useful instead.

MK-677 (ibutamoren) is a ghrelin mimetic and growth hormone secretagogue. It raises IGF-1 and GH pulse amplitude without being a peptide itself. A 2008 study by Nass et al. in the Journal of Clinical Endocrinology and Metabolism found significant IGF-1 increases in older adults but also documented fluid retention and increased fasting glucose. It is not FDA-approved. Enclomiphene is a selective estrogen receptor modulator sometimes used off-label to stimulate endogenous testosterone production. A 2013 trial by Kim et al. in BJU International found it raised testosterone while maintaining sperm parameters better than exogenous TRT in hypogonadal men. Neither compound is without meaningful risk, and neither is a regulated first-line treatment in the US.

What did they get wrong (or right)?

The creator did not get anything medically wrong because they made no medical statements. What the video does do, unintentionally or not, is normalize casual reference to prescription-adjacent compounds in a context stripped of any safety information. The juxtaposition of lyrics about mental illness with hashtags about "gear" and physique optimization is worth noting without overreading it.

What they got right, inadvertently: they did not make inflated efficacy claims, did not prescribe a dose, and did not tell anyone to buy anything. In a space full of creators confidently explaining how to self-administer peptide stacks with zero credentials, saying nothing is arguably less harmful than saying something wrong. That is a low bar, but it clears it.

What should you actually know?

If you found this video while researching enclomiphene or MK-677, here is what the evidence supports without embellishment. Enclomiphene can raise testosterone in men with secondary hypogonadism, but it requires baseline labs to confirm the diagnosis and monitoring to assess response. Using it without knowing your LH, FSH, and total testosterone baseline is guesswork. MK-677 raises GH and IGF-1, but the clinical tradeoffs, including insulin resistance and potential for long-term GH axis dysregulation, are not trivial and are not settled in the literature.

Both compounds are available through compounding pharmacies and gray-market vendors. Compounded versions are not equivalent to any FDA-approved reference product. Quality, purity, and concentration vary. Anyone considering either compound should be working with a licensed provider who orders baseline labs, not taking cues from TikTok captions.

  • Do not stack MK-677 with other compounds that affect insulin sensitivity without medical supervision.
  • Enclomiphene is not a substitute for diagnosing the underlying cause of low testosterone.
  • Mental health symptoms, which the lyrics here reference directly, can both mimic and cause hormonal dysregulation. That connection deserves clinical evaluation, not self-experimentation.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Enclomiphene and MK-677 stacking claims: what the data says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Enclomiphene and MK-677 stacking claims: what the data says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim verdict

The useful answer behind this video

Claim being checked

The video contains no clinical claims about MK-677 or enclomiphene.

FormBlends verdict

The video contains no clinical claims about MK-677 or enclomiphene. The caption implies an update on both compounds, but the audio is song lyrics referencing mental illness and social fear. Viewers seeking compound information will find none here, and any health decisions about MK-677 or enclomiphene should be based on supervised lab work and licensed provider guidance, not social media captions.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The video contains no clinical claims about MK-677 or enclomiphene. The caption implies an update on both compounds, but the audio is song lyrics referencing mental illness and social fear. Viewers seeking compound information will find none here, and any health decisions about MK-677 or enclomiphene should be based on supervised lab work and licensed provider guidance, not social media captions.
  • This video contains zero spoken claims about MK-677 or enclomiphene. The transcript is song lyrics.
  • MK-677 raised IGF-1 significantly in a 2008 Nass et al. trial but also increased fasting glucose and caused fluid retention. It is not FDA-approved.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • This video contains zero spoken claims about MK-677 or enclomiphene. The transcript is song lyrics.
  • MK-677 raised IGF-1 significantly in a 2008 Nass et al. trial but also increased fasting glucose and caused fluid retention. It is not FDA-approved.
  • A 2013 Kim et al. trial in BJU International found enclomiphene raised testosterone while preserving sperm production, but the study population was clinically diagnosed hypogonadal men with supervised monitoring.
  • Compounded MK-677 and enclomiphene are not FDA-approved and are not equivalent to any reference drug in purity, concentration, or regulatory oversight.
  • Mental health symptoms referenced in the lyrics, including social fear and chronic low mood, can both reflect and drive hormonal imbalances. Self-treating either without diagnosis is not a sound approach.
  • Anyone considering these compounds should get baseline labs including LH, FSH, total testosterone, IGF-1, and fasting glucose before starting, and be monitored by a licensed provider throughout.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

derealization · TikTok creator

23.5K views on this video

Rad enclo an mk update #gear #gym #gymupdate #physique #meltmaxxing

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by derealization, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.